H&R GmbH & Co. KGaA / DE000A2E4T77

H&R continues its recovery during the year with nine-month figures 2023

H&R GmbH & Co. KGaA / Key word(s): 9 Month figures/Quarterly / Interim Statement
H&R continues its recovery during the year with nine-month figures 2023

15.11.2023 / 10:11 CET/CEST
The issuer is solely responsible for the content of this announcement.

---

H&R GmbH & Co. KGaA: Quarterly Report for third quarter of 2023 Third quarter delivers highest earnings contribution: EBITDA of EUR 66.6 million in the first nine months Further significant improvement in cash positions Slightly more optimistic expectations for the year as a whole   Salzbergen, Germany, November 15, 2023. H&R GmbH & Co. KGaA (short: H&R KGaA; ISIN DE000A2E4T77) has confirmed its preliminary sales and earnings figures for the third quarter of 2023: From July to September 2023, the company achieved an operating result (EBITDA - consolidated earnings before income taxes, other financial income and expenses as well as amortization, depreciation and impairment losses and write-ups on intangible assets and property, plant and equipment) of EUR 27.2 million (same period of the previous year: EUR 30.5 million). The recovery during the year continued: The third quarter of 2023 delivered the highest contribution to earnings this year. EBIT closed at EUR 13.0 million, down from last year's EUR 17.2 million. Earnings before taxes (EBT) for Q3-2023 were EUR 9.6 million (Q3-2022: EUR 15.3 million), and the company closed at EUR 7.6 million for consolidated net income attributable to shareholders (Q3-2022: EUR 10.4 million). Sales in the third quarter of the current fiscal year were reduced to EUR 337.2 million (Q3-2022: EUR 418.7 million), mainly due to higher raw material costs compared to the previous year. Overview of key figures:

in million EUR	Nine months 2023	Nine Months 2022	Diff. abs.
Sales Revenues	1,036.8	1,224.5	-187.7
ChemPharm REFINING	634.1	802.7	-168.6
ChemPharm SALES	380.1	401.8	-21.7
PLASTICS	38.3	34.2	4.1
Consolidation	-15.7	-14.2	-1.5
Operative Earnings (EBITDA)	66.6	103.3	-36.7
ChemPharm REFINING	43.2	74.3	-31.1
ChemPharm SALES	21.9	29.6	-7.7
PLASTICS	3.0	2.4	-0.6
Consolidation	-1.5	-3.1	1.6
EBIT	24.1	63.4	-39.3
Earnings before Taxes	15.2	58.2	-43.0
Net Income attributable to Shareholders	11.3	40.1	-28.8
Earnings per Share (in EUR)	0.30	1.08	-0.78
Operative Cashflow	101.7	-9.0	110.7
Free Cashflow	58.4	-60.3	118.7
	Q3 2023	Q3 2022	Diff. abs.
Sales Revenues	337.2	418.7	-81.5
ChemPharm REFINING	200.9	268.4	-67.5
ChemPharm SALES	129.0	141.9	-12.9
PLASTICS	12.0	13.1	-1.1
Consolidation	-4.7	-3.9	-0.8
Operative Earnings (EBITDA)	27.2	30.5	-3.3
ChemPharm REFINING	20.9	19.4	1.5
ChemPharm SALES	8.0	10.9	-2.9
PLASTICS	0.0	1.1	-1.1
Consolidation	-1.7	-0.9	-0.8
EBIT	13.0	17.2	-4.2
Earnings before Taxes	9.6	15.3	-5.7
Net Income attributable to Shareholders	7.6	10.4	-2.8
Earnings per Share (in EUR)	0.20	0.28	-0.08
Operative Cashflow	44.6	-7.6	52.5
Free Cashflow	33.8	-31.6	65.4
	30/09/2023	31/12/2022	Diff. abs.
Balance Sheet Total	926.9	962.1	-35.2
Equity	466.9	471.2	-4.3
Equity Ratio (in %, difference in percentage points)	50.4	49.0	1.4

    Following the increase in the lower range of its guidance two weeks ago, the company currently continues to expect to achieve the target of EUR 80.0 million minimum. The upper range of EUR 90.0 million remains unchanged. For further information on the business and earnings development, the company refers to the Quarterly Statement on Q3 2023 published today, which can be downloaded from www.hur.com in the "Investor Relations" section. Contact information: H&R GmbH & Co. KGaA, Head of Investor Relations/Communications, Ties Kaiser Neuenkirchener Strasse 8, 48499 Salzbergen Tel.: [phone], Fax: [phone] e-mail: [e-mail] ; www.hur.com   H&R GmbH & Co. KGaA: H&R KGaA is a specialty-chemicals company listed on the Frankfurt Stock Exchange's Prime Standard segment. It develops and manufactures fossil-, biomass-, synthetic- and recycle-based hydrocarbon chemical and pharmaceutical specialty products and produces high-precision plastic parts.   Forward-looking statements and forecasts: This press release contains forward-looking statements. The statements are based on the current estimates and forecasts by the Executive Board and the information available to the Board at this time. These forward-looking statements do not provide any warranty for the future developments and results contained therein. The future developments and results are dependent on a number of factors; they entail various risks and contingencies and are based on assumptions which could prove to be incorrect. We do not assume any responsibility for updating the forward-looking statements contained in this press release.

---

15.11.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---

Language:	English
Company:	H&R GmbH & Co. KGaA
	Neuenkirchener Str. 8
	48499 Salzbergen
	Germany
Phone:	[phone]
Fax:	[phone]
E-mail:	[e-mail]
Internet:	www.hur.com
ISIN:	DE000A2E4T77
WKN:	A2E4T7
Listed:	Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Hamburg; Regulated Unofficial Market in Berlin, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID:	1774069

End of News	EQS News Service

---

1774069  15.11.2023 CET/CEST